Latest news
The Manufacturers Life Insurance Company Raises Stake in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:13:44 GMTDimensional Fund Advisors LP Acquires 473,005 Shares of Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:49:35 GMTJPMorgan Chase & Co. Has Lowered Expectations for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 18:44:16 GMTWells Fargo & Company Lowers Monte Rosa Therapeutics (NASDAQ:GLUE) Price Target to $27.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:59:27 GMTZacks Research Upgrades Monte Rosa Therapeutics (NASDAQ:GLUE) to "Hold" - MarketBeatMarketBeat · Thu, 06 Aug 2026 12:11:30 GMTJanus Henderson Group PLC Invests $11.29 Million in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Wed, 05 Aug 2026 09:39:02 GMTRenaissance Technologies LLC Makes New Investment in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Wed, 05 Aug 2026 09:27:33 GMTMonte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 4.1% After Analyst Downgrade - MarketBeatMarketBeat · Mon, 03 Aug 2026 15:32:32 GMT